Athersys, Inc
ATHXDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001368148
Athersys, Inc was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Dec 21, 2023; 43 institutions reported holding it in 13F filings for Q3 2023, worth $1.18M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Athersys, Inc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- −73 vs. Q2 2022
- Shares held
- 2.23M
- +551.4K (+32.9%) vs. Q2 2022Converted for a 1-for-25 split
- Total value
- $4.11M
- −$6.78M (−62.3%) vs. Q2 2022
- New holders
- 4
- 12 more added
- Sold out
- 77
- 15 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ATHX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 2 | $0 |
| Q1 2025 | 2 | $0 |
| Q4 2024 | 4 | $0 |
| Q3 2024 | 4 | $0 |
| Q2 2024 | 4 | $3 |
| Q1 2024 | 4 | $5 |
| Q4 2023 | 7 | $5.51K |
| Q3 2023 | 43 | $1.18M |
| Q2 2023 | 46 | $3.79M |
| Q1 2023 | 47 | $2.78M |
| Q4 2022 | 50 | $1.67M |
| Q3 2022 | 44 | $4.11M |
| Q2 2022 | 117 | $10.9M |
| Q1 2022 | 125 | $33.6M |
| Q4 2021 | 130 | $49.2M |
| Q3 2021 | 141 | $68.4M |
| Q2 2021 | 140 | $73.2M |
| Q1 2021 | 140 | $108.0M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Athersys, Inc; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Game Plan Financial Advisors, LLC | 0 | $0 | 0.00% | −760−100.0% | Sold outConverted for a 1-for-25 split |
| Ameritas Advisory Services, LLC | 0 | $0 | 0.00% | −701−100.0% | Sold outConverted for a 1-for-25 split |
| Legal & General Group Plc | 0 | $0 | 0.00% | −680−100.0% | Sold outConverted for a 1-for-25 split |
| Intercontinental Wealth Advisors, LLC | 0 | $0 | 0.00% | −608−100.0% | Sold outConverted for a 1-for-25 split |
| Cresset Asset Management, LLC | 0 | $0 | 0.00% | −630−100.0% | Sold outConverted for a 1-for-25 split |
| Glenmede Trust Co NA | 0 | $0 | 0.00% | −500−100.0% | Sold outConverted for a 1-for-25 split |
| Umb Bank N A | 0 | $0 | 0.00% | −400−100.0% | Sold outConverted for a 1-for-25 split |
| Raymond James & Associates | 0 | $0 | 0.00% | −404−100.0% | Sold outConverted for a 1-for-25 split |
| Chicago Partners Investment Group LLC | 0 | $0 | 0.00% | −440−100.0% | Sold outConverted for a 1-for-25 split |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −528−100.0% | Sold outConverted for a 1-for-25 split |
| Retirement Group, LLC | 0 | $0 | 0.00% | −400−100.0% | Sold outConverted for a 1-for-25 split |
| Magnus Financial Group LLC | 0 | $0 | 0.00% | −400−100.0% | Sold outConverted for a 1-for-25 split |
| Arlington Partners LLC | 0 | $0 | 0.00% | −251−100.0% | Sold outConverted for a 1-for-25 split |
| FMR LLC | 0 | $0 | 0.00% | −111−100.0% | Sold outConverted for a 1-for-25 split |
| Citigroup Inc | 0 | $0 | 0.00% | −88−100.0% | Sold outConverted for a 1-for-25 split |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −160−100.0% | Sold outConverted for a 1-for-25 split |
| Vectors Research Management, LLC | 0 | $0 | 0.00% | −160−100.0% | Sold outConverted for a 1-for-25 split |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −76−100.0% | Sold outConverted for a 1-for-25 split |
| Credit Suisse AG | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-25 split |
| Ellevest, Inc. | 0 | $0 | 0.00% | −27−100.0% | Sold outConverted for a 1-for-25 split |
| Curi Capital | 0 | $0 | 0.00% | −40−100.0% | Sold outConverted for a 1-for-25 split |